Eylea vs Lucentis

Eylea
(Rx)
Lucentis
(Rx)
Eylea is an eye & vision care product.
Lucentis is an eye & vision care product.
Satisfaction Score
?
No score available
Satisfaction Score
?
3.7
Moderately Satisfied
Concern level
1.7
Approval Date
+ -
November 18, 2011
June 30, 2006
Number of discussions around the web Number of discussions + -
234 Discussions
1,955 Discussions
Taken For
+ -
Condition
Number of posts
Eylea is prescribed for Age-Related Macular Degeneration and Eye Disease and is mostly mentioned together with these indications.
Condition
Number of posts
Lucentis is prescribed for Wet Macular Degeneration, Macular Degeneration, Age-Related Macular Degeneration, Macular Edema and Diabetic Macular Edema and is mostly mentioned together with these indications.
Side Effects and Concerns
+ -
Eyl
Cataract
9
High Blood Pressure
4
Itching
4
Dry Eyes
4
Tiredness
4
Floaters
4
Allergy
4
Bad Vision
4
Discomfort
4
Anxiety
3
Luc
Nearsighted
4
Discomfort
3
Blurred Vision
3
Tiredness
2
Floaters
2
Depression
2
High Blood Pressure
1
Stroke
1
Itching
1
Double Vision
1
Compare concerns
By:
Eylea
Eyl
Lucentis
Luc
Cataract
Eyl
Luc
9
0
High Blood Pressure
Eyl
Luc
4
1
Itching
Eyl
Luc
4
1
Dry Eyes
Eyl
Luc
4
0
Tiredness
Eyl
Luc
4
2
Floaters
Eyl
Luc
4
2
Allergy
Eyl
Luc
4
0
Bad Vision
Eyl
Luc
4
0
Discomfort
Eyl
Luc
4
3
Anxiety
Eyl
Luc
3
0
Nearsighted
Luc
Eyl
4
0
Discomfort
Luc
Eyl
3
4
Blurred Vision
Luc
Eyl
3
0
Tiredness
Luc
Eyl
2
4
Floaters
Luc
Eyl
2
4
Depression
Luc
Eyl
2
0
High Blood Pressure
Luc
Eyl
1
4
Stroke
Luc
Eyl
1
0
Itching
Luc
Eyl
1
4
Double Vision
Luc
Eyl
1
0
Pregnancy Category (FDA) OpenClose all pregnancy categories
+ -
a b c d x n
Category A
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Category N
FDA has not classified the drug.
close
C Category C
Before taking Eylea during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Not Available
Alcohol warning
+ -
There may be a negative interaction between Eylea and alcohol.
There may be a negative interaction between Lucentis and alcohol.
Method of use
+ -
Dosages
+ -
Solution: 2 mg/0.05 mL
Solution: 0.3 mg/0.05 mL, 0.5 mg/0.05 mL
Food Instructions
+ -
No Food Instructions
No Food Instructions
Ingredients
+ -
Aflibercept
Ranibizumab
Drug Interactions
+ -
Interaction between Eylea and Lucentis: Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
Read more about:
Eylea
Read more about:
Lucentis
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 92 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Please wait...